Announcements
SickKids Corporate Ventures Office Licenses New Compound that May Treat Lysosomal Storage and Neurological Disorders
The Hospital for Sick Children (SickKids) has licensed its rights to a new compound to Neuraltus Pharmaceuticals in order to further research and development, and move the technology into clinical trials. The compound, which was developed in collaboration with Neuraltus, may be useful in treating certain lysosomal storage disorders and neurological disorders. Read more.
SickKids Corporate Ventures Office Licenses Peptide Discovered by Research Institute Scientists to Treat Chronic Pain
A new pharmaceutical technology licensed in February by the Corporate Ventures office at The Hospital for Sick Children (SickKids) may help treat neuropathic and inflammatory pain in children and adults, but without the serious side effects that can accompany currently available treatments. Read more.
SickKids Knowledge Partnerships Launches Toddler Care Book
“strategies to help parents deal with toddler issues.”
Dr.Jeremy Friedman, Head of Paediatric Medicine, has come out with a third book, Canada’s Toddler Care Book, a comprehensive guide that presents information in a friendly, easy-to-understand style for parents. This is a follow-up to the bestselling Canada’s Baby Care Book, launched in 2007. Read more.
SickKids Knowledge Partnerships Launches New Edition of SickKids Handbook of Pediatrics
The 11th edition of The Hospital for Sick Children Handbook of Pediatrics, led by staff editors Drs. Anne Dipchand and Jeremy Friedman, with resident editors Drs. Zia Bismilla, Sumit Gupta and Catherine Lam, has just been published! The new edition is designed to be the essential paediatric reference for use in any health-care setting. Read more.